The National Institutes of Health has pledged $275 million to fund two multi-year research programs, including studies to discover the causes and cures for rare and undiagnosed diseases, according to an article published by the Burrill Report. The new strategic funding from NIH’s Common Fund includes $145 million in funding over the next seven years for the Undiagnosed Diseases Program (UDP) to provide a new network of medical research centers focused on the discovery, diagnosis, and care of undiagnosed patients. Of the $275 million, $130 million is being directed to the Extracellular RNA Communication program to understand how RNA outside of a cell is involved in cellular communication.
“This program will spawn new medical discoveries and accelerate clinical investigations that will ultimately improve the lives of thousands of patients living with undiagnosed diseases,” said Francis Collins, Director of NIH. “Establishing a national network of clinical research centers is a critical first step towards addressing the need for more rapid and coordinated approaches to diagnose and manage rare undiagnosed diseases.”
The National Institutes of Health (NIH) is the leading medical research agency in the United States. As the primary federal agency for medical research, the NIH focuses on research, investigation and treatment for rare diseases, common or otherwise.
For more information, visit NIH.gov.